Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Par Pharmaceutical Halts Shipment of Inhalation Suspension | Contract Pharma

What are you searching for?

Sign in
Breaking News

Par Pharmaceutical Halts Shipment of Inhalation Suspension

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The U.S. District Court for the District of New Jersey has granted AstraZeneca Pharmaceuticals‘ motion for a temporary restraining order (TRO) halting sales of Teva’s generic Pulmicort Respules (budesonide inhaled solution). In conjunction with the order against Teva, AZ will also stop all sales of its authorized generic budesonide inhalation suspension product and take the necessary steps to comply with the Court’s decision. Par Pharmaceutical is the licensed distributor for AZ’s generic version of Pulmicort Respules.
   
The TRO remains in effect until further notice by the Court. This action does not impact sales of branded Pulmicort Respules.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters